Abstract: This letter proposes a novel Data-Driven (DD) method for controlling unknown input-affine nonlinear systems. First, we estimate the system dynamics from noisy data offline through Subspace ...

After the basics, focus on core data structures like stacks, queues, linked lists, sets, and maps, and algorithms such as sorting, binary search, two pointers, and greedy methods. Understanding when ...

Java mastery goes beyond syntax—it’s about understanding its principles, applying best practices, and optimizing for performance. From core concepts like arrays and OOP to advanced interview ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

A hot potato: GitHub has announced that starting April 24, the company will begin using interaction data from Copilot Free, Pro, and Pro+ users to train and improve its AI models unless they opt out.

Democratic senator Elizabeth Warren and Republican senator Josh Hawley are urging the US’s central energy information agency to provide better information on how much electricity data centers actually ...

This story is part of a Seattle Times focus on the affordability crisis in the Northwest. We explore the high cost of living and wealth disparities that shape our region; examine policies that impact ...

The Trump administration’s move to give deportation officials access to Medicaid data is putting hospitals and states in a bind as they weigh whether to alert immigrant patients that their personal ...

Driven by the artificial intelligence frenzy, Microsoft is internally projecting that water use at its data centers will more than double by 2030 from 2020, including in places that face shortages.

Forbes contributors publish independent expert analyses and insights. Randy Bean is a noted Senior Advisor, Author, Speaker, Founder, & CEO. This voice experience is generated by AI. Learn more. This ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...